Octreotide and Glucagon · Minor SPL band
SPL labels Octreotide + Glucagon as minor; Octreotide 5 / Glucagon 14 in that band.
Mechanism on file: Octreotide blocks the body from releasing its own glucagon. This can interfere with how the body naturally controls blood sugar levels.
FDA SPL severity: Minor
Octreotide + Glucagon · SPL mechanism field
Octreotide blocks the body from releasing its own glucagon. This can interfere with how the body naturally controls blood sugar levels.
Minor band excerpt · Octreotide with Glucagon
7.2 Insulin and Oral Hypoglycemic Drugs Octreotide inhibits the secretion of insulin and glucagon.
Octreotide · 5 minor + 14 total pairs
- Bromocriptine minor
- Cyclosporine minor
- Nateglinide minor
- Repaglinide minor
Glucagon · 14 minor + 14 total pairs
- Glimepiride minor
- Indomethacin minor
- Insulin Aspart minor
- Insulin Degludec minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.